We speculate that this may reflect the influence of factors other than estrogens in eADA control in ApoE-/-LDL-R-/- mice, for example, in the appearance of an inflammatory state during development of atherosclerosis, which may influence the interaction of estradiol with the purinergic system [36–38]. The gene discussed is LDLR; the disease is atherosclerosis.